We are live on ! Find out more
QTTB icon

Q32 Bio

102 hedge funds and large institutions have $574M invested in Q32 Bio in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 14 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

271% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 14

85% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 13

12% more funds holding

Funds holding: 91102 (+11)

0.04% more ownership

Funds ownership: 4.6%4.64% (+0.04%)

1% less capital invested

Capital invested by funds: $582M → $574M (-$7.95M)

60% less funds holding in top 10

Funds holding in top 10: 52 (-3)

82% less call options, than puts

Call options by funds: $250K | Put options by funds: $1.4M

Holders
102
Holders Change
+11
Holders Change %
+12.09%
% of All Funds
2.09%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.04%
New
24
Increased
52
Reduced
14
Closed
13
Calls
$250K
Puts
$1.4M
Net Calls
-$1.15M
Net Calls Change
-$549K
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$2.84M +$487K +1,826 +21%
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$2.25M +$2.19M +8,226 New
MAM
28
Martingale Asset Management
Massachusetts
$2.2M +$2.15M +8,051 New
EAM
29
Erste Asset Management
Austria
$2.09M
CAC
30
Cowen and Company
New York
$2M -$5.11M -19,159 -72%
N
31
Nuveen
North Carolina
$1.92M +$493K +1,851 +36%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.78M +$415K +1,558 +32%
Victory Capital Management
33
Victory Capital Management
Texas
$1.56M -$8.54M -32,033 -85%
Verition Fund Management
34
Verition Fund Management
Connecticut
$1.39M +$1.35M +5,066 New
Renaissance Technologies
35
Renaissance Technologies
New York
$1.37M +$539K +2,023 +68%
Ameriprise
36
Ameriprise
Minnesota
$1.33M -$436K -1,634 -25%
Bessemer Group
37
Bessemer Group
New Jersey
$1.14M +$1.11M +4,156 New
SCM
38
Suvretta Capital Management
New York
$1.07M +$29.1K +109 +3%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$1.07M +$1.05M +3,926 New
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.04M +$198K +742 +24%
HAM
41
HHR Asset Management
New Jersey
$1.01M -$162K -609 -14%
TD Asset Management
42
TD Asset Management
Ontario, Canada
$888K +$32.5K +122 +4%
Swiss National Bank
43
Swiss National Bank
Switzerland
$822K +$240K +900 +43%
Arrowstreet Capital
44
Arrowstreet Capital
Massachusetts
$805K +$785K +2,944 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$778K +$204K +767 +37%
CM
46
Caption Management
Oklahoma
$763K +$743K +2,789 New
CS
47
Credit Suisse
Switzerland
$752K +$583K +2,187 +387%
Citigroup
48
Citigroup
New York
$749K +$403K +1,513 +123%
Allianz Asset Management
49
Allianz Asset Management
Germany
$742K -$533K -1,998 -42%
Russell Investments Group
50
Russell Investments Group
United Kingdom
$699K +$164K +617 +32%

QTTB Hedge Fund Activity: Q2 2020 in Review

102 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q2 2020, worth a combined $574M — down 1.4% from $582M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new QTTB positions and 13 closed out — a net gain of 11 holders — while 52 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $10.4M. The largest seller was Deerfield Management, exiting entirely with an estimated $62.7M sold.

  • 102 institutional investors held Q32 Bio (QTTB) as of Q2 2020, up from 91 in Q1 2020.
  • Funds reported $574M of Q32 Bio stock for Q2 2020, down 1.4% quarter-over-quarter.
  • 24 funds opened new Q32 Bio positions in Q2 2020 and 13 closed out, a net change of +11 holders.
  • The largest Q32 Bio buyer in Q2 2020 was BlackRock, an estimated $10.4M added.
  • The largest Q32 Bio seller in Q2 2020 was Deerfield Management, an estimated $62.7M sold.

Based on aggregated 13F filings for Q2 2020.